|
|
|
ExlPharma, Barcelona, Spain
10/30/08-10/31/08
DMC's will offer an opportunity for a team of experts, independent from the trial sponsor, to examine the interim clinical data and make unbiased recommendations for the continuation, alteration and termination of the trial.
|
|
|
|
|
|
Organized by:
|
|
ExlPharma |
|
Invited Speakers:
|
|
Jonathan Seltzer, President of Applied Clinical Intelligence James Matcham, Director, Biostatistics, Amgen UK
|
|
|
|
|
|
Deadline for Abstracts:
|
|
09/19/08
|
|
|
|
|
|
Registration:
|
|
Fax: 212-400-9408 Mail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018
|
|
E-mail:
|
|
registration@exlpharma.com
|
|
|
|
|
|
|
|